TenX Keane Acquisition extends deadline to June 18, 2024 via $66,667 deposit from Citius Pharma

CITIUS ONCOLOGY, INC.

Citius Pharma deposited $66,667 on May 17, 2024 to extend business combination deadline from May 18 to June 18, 2024.
The deposit is the second of up to seven monthly extensions allowed under the charter, originally expiring April 18, 2024.
The extension is funded via an unsecured, non-interest-bearing promissory note repayable upon consummation of the business combination.
Repayment of the note is conditioned on the trust account balance equaling or exceeding $2.0 million at closing of the merger with Citius Oncology.
The merger agreement with Citius Pharmaceuticals and Citius Oncology was dated October 23, 2023, and remains pending.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.